Abstract
Purpose
To analyse technical and clinical success of transjugular intrahepatic portosystemic shunt (TIPS) in patients with portal hypertension and compare a stent and a stentgraft with regard to clinical and technical outcome and associated costs.
Materials and Methods
170 patients (56 ± 12 years, 32.9 % females) treated with TIPS due to portal hypertension were reviewed. 80 patients received a stent (group 1) and 83 a stentgraft (group 2), and seven interventions were unsuccessful. Technical data, periprocedural imaging, follow-up ultrasound and clinical data were analysed with focus on technical success, patency, clinical outcome and group differences. Cost analysis was performed.
Results
Portal hypertension was mainly caused by ethyltoxic liver cirrhosis with ascites as dominant symptom (80 %). Technical success was 93.5 % with mean portosystemic gradient decrease from 16.1 ± 4.8 to 5.1 ± 2.1 mmHg. No significant differences in technical success and portosystemic gradient decrease between the groups were observed. Kaplan–Meier analysis yielded significant differences in primary patency after 14 days, 6 months and 2 years in favour of the stentgraft. Both groups showed good clinical results without significant difference in 1-year survival and hepatic encephalopathy rate. Costs to establish TIPS and to manage 2-year follow-up with constant patency and clinical success were 8876 € (group 1) and 9394 € (group 2).
Conclusion
TIPS is a safe and effective procedure to manage portal hypertension. Stent and stentgraft enabled good technical and clinical results with a low complication rate. Primary patency rates are clearly in favour of the stentgraft, whereas the stent was more cost effective with similar clinical results in both groups.
Similar content being viewed by others
References
Fidelman N, Kwan SW, LaBerge JM, Gordon RL, Ring EJ, Kerlan RK Jr. The transjugular intrahepatic portosystemic shunt: an update. Am J Roentgenol. 2012;199(4):746–55.
García-Pagán JC, Caca K, Bureau C, Laleman W, Appenrodt B, Luca A, Abraldes JG, Nevens F, Vinel JP, Mössner J, Bosch J. Early use of TIPS in patients with cirrhosis and variceal bleeding. N Engl J Med. 2010;362(25):2370–9.
Boyer TD, Haskal ZJ. American Association for the Study of Liver Diseases: the role of transjugular intrahepatic portosystemic shunt in the management of portal hypertension. Hepatology. 2005;41(2):386–400.
Rösch J, Hanafee WN, Snow H. Transjugular portal venography and radiologic portacaval shunt: an experimental study. Radiology. 1969;92(5):1112–4.
Rossle M, Siegerstetter V, Olschewski M, Ochs A, Berger E, Haag K. How much reduction in portal pressure is necessary to prevent variceal rebleeding? A longitudinal study in 225 patients with transjugular intrahepatic portosystemic shunts. Am J Gastroenterol. 2001;96(12):3379–83.
Burgener FA, Gutierrez OH. Production of nonsurgical intrahepatic portacaval shunt in portal hypertension using a Gruntzig balloon dilatation catheter. J Radiol. 1985;66(1):7–11.
Barton RE, Rösch J, Saxon RR, Lakin PC, Petersen BD, Keller FS. TIPS short- and long-term results: a survey of 1750 patients. Semin Interv Radiol. 1995;12(4):364–7.
Richter GM, Palmaz JC, Nöldge G, Rossle M, Siegerstetter V, Franke M, Wenz W. The transjugular intrahepatic portosystemic stent-shunt: a new nonsurgical percutaneous method. Der Radiologe. 1989;29(8):406–11.
Marquardt S, Rodt T, Rosenthal H, Wacker F, Meyer BC. Impact of anatomical, procedural, and operator skill factors on the success and duration of fluoroscopy-guided transjugular intrahepatic portosystemic shunt. Cardiovasc Interv Radiol. 2014;38(4):903–12.
Bureau C, Pagan JCG, Layrargues GP, Metivier S, Bellot P, Perreault P, Otal P, Abraldes JG, Peron JM. Patency of stents covered with polytetrafluoroethylene in patients treated by transjugular intrahepatic portosystemic shunts: long-term results of a randomized multicentre study. Liver Int. 2007;27(6):742–7.
Qi X, Guo X, Fan D: A trend toward the improvement of survival after tips by the use of covered stents: a meta-analysis of two randomized controlled trials. Cardiovasc Interv Radiol. (2014) [Epub ahead of print]
D’amico G, Tarantino G, Spaggiari M, Ballarin R, Serra V, Rumpianesi G, Montalti R, De Ruvo N, Cautero N. Multiple ways to manage portal thrombosis during liver transplantation: surgical techniques and outcomes. Transpl Proc. 2013;45(7):2692–9.
D’amico G, Luca A, Morabito A, Miraglia R. D’amico M: Uncovered transjugular intrahepatic portosystemic shunt for refractory ascites: a meta-analysis. Gastroenterology. 2005;129(4):1282–93.
Gülberg V, Schepke M, Geigenberger G, Holl J, Brensing KA, Waggershauser T, Reiser M, Schild HH, Sauerbruch T. Transjugular intrahepatic portosystemic shunting is not superior to endoscopic variceal band ligation for prevention of variceal rebleeding in cirrhotic patients: a randomized, controlled trial. Scand J Gastroenterol. 2002;37(3):338–43.
Burroughs AK, Vangeli M. Transjugular intrahepatic portosystemic shunt versus endoscopic therapy: randomized trials for secondary prophylaxis of variceal bleeding: an updated meta-analysis. Scand J Gastroenterol. 2002;37(3):249–52.
Hidajat N, Wust P, Kreuschner M, Felix R, Schröder R-J. Radiation risks for the radiologist performing transjugular intrahepatic portosystemic shunt (TIPS). Br J Radiol. 2006;79(942):483–6.
Bureau C, García-Pagán JC, Otal P, Pomier-Layrargues G, Chabbert V, Cortez C, Perreault P, Peron JM, Abraldes JG. Improved clinical outcome using polytetrafluoroethylene-coated stents for TIPS: results of a randomized study. Gastroenterology. 2004;126(2):469–75.
Kaplan RS: Accounting & Management: Harvard Business Press, ISBN 9780875841861 (1987)
Saad WEA, Darwish WM, Davies MG, Waldman DL. Stent-grafts for transjugular intrahepatic portosystemic shunt creation: specialized TIPS stent-graft versus generic stent-graft/bare stent combination. J Vasc Interv Radiol. 2010;21(10):1512–20.
Rousseau H, Vinel JP, Bilbao JI, Longo JM, Maquin P, Zozaya JM, Garcia-Villareal L, Coustet B, Railhac N. Transjugular intrahepatic portosystemic shunts using the Wallstent prosthesis: a follow-up study. Cardiovasc Interv Radiol. 1994;17(1):7–11.
Hausegger KA, Karnel F, Georgieva B, Tauss J, Portugaller H, Deutschmann H, Berghold A. Transjugular intrahepatic portosystemic shunt creation with the Viatorr expanded polytetrafluoroethylene-covered stent-graft. J Vasc Interv Radiol. 2004;15(3):239–48.
Boyer TD, Haskal ZJ. American Association for the Study of Liver Diseases: the Role of Transjugular Intrahepatic Portosystemic Shunt (TIPS) in the management of portal hypertension: update 2009. Hepatology. 2010;51(1):306.
Ochs A. Transjugular intrahepatic portosystemic shunt. Dig Dis (Basel, Switzerland). 2005;23(1):56–64.
Yang Z, Han G, Wu Q, Ye X, Jin Z, Yin Z, Qi X, Bai M, Wu K. Patency and clinical outcomes of transjugular intrahepatic portosystemic shunt with polytetrafluoroethylene-covered stents versus bare stents: a meta-analysis. J Gastroenterol Hepatol. 2010;25(11):1718–25.
Casado M, Bosch J, García-Pagán JC, Bru C, Bañares R, Bandi JC, Escorsell A, Rodríguez-Láiz JM, Gilabert R. Clinical events after transjugular intrahepatic portosystemic shunt: correlation with hemodynamic findings. Gastroenterology. 1998;114(6):1296–303.
Rössle M. TIPS 25 years later. J Hepatol. 2013;59(5):1081–93.
Fitsiori K, Tsitskari M, Kelekis A, Filippiadis D, Triantafyllou K, Brountzos E. Transjugular intrahepatic portosystemic shunt for the treatment of budd-Chiari syndrome patients: results from a single center. Cardiovasc Interv Radiol. 2014;37(3):691–7.
Tripathi D, Macnicholas R, Kothari C, Sunderraj L, Al-Hilou H, Rangarajan B, Chen F, Mangat K, Elias E. Good clinical outcomes following transjugular intrahepatic portosystemic stent-shunts in Budd-Chiari syndrome. Aliment Pharmacol Ther. 2014;39(8):864–72.
Barrio J, Ripoll C, Bañares R, Echenagusia A, Catalina M-V, Camúñez F, Simó G, Santos L. Comparison of transjugular intrahepatic portosystemic shunt dysfunction in PTFE-covered stent-grafts versus bare stents. Eur J Radiol. 2005;55(1):120–4.
Tripathi D, Helmy A, Macbeth K, Balata S, Lui HF, Stanley AJ, Redhead DN, Hayes PC. Ten years’ follow-up of 472 patients following transjugular intrahepatic portosystemic stent-shunt insertion at a single centre. Eur J Gastroenterol Hepatol. 2004;16(1):9–18.
Sommer CM, Gockner TL, Stampfl U, Bellemann N, Sauer P, Ganten T, Weitz J, Kauczor HU, Radeleff BA. Technical and clinical outcome of transjugular intrahepatic portosystemic stent shunt: bare metal stents (BMS) versus viatorr stent-grafts (VSG). Eur J Radiol. 2012;81(9):2273–80.
Tripathi D, Ferguson J, Barkell H, Macbeth K, Ireland H, Redhead DN, Hayes PC. Improved clinical outcome with transjugular intrahepatic portosystemic stent-shunt utilizing polytetrafluoroethylene-covered stents. Eur J Gastroenterol Hepatol. 2006;18(3):225–32.
Hamid RS, Hamid RS, Azeemuddin M, Sajjad Z, Chishti I. Salam, Basit: Transjugular intrahepatic portosystemic shunt (TIPS); review of initial experience at Aga Khan University Hospital. J Pak Med Assoc. 2011;61(4):336–9.
Angermayr B, Cejna M, Koenig F, Karnel F, Hackl F, Gangl A, Peck-Radosavljevic M. Vienna TIPS Study Group: Survival in patients undergoing transjugular intrahepatic portosystemic shunt: ePTFE-covered stentgrafts versus bare stents. Hepatology. 2003;38(4):1043–50.
Gaba RC, Omene BO, Podczerwinski ES, Knuttinen MG, Cotler SJ, Kallwitz ER, Berkes JL, Walzer NM, Bui JT. TIPS for treatment of variceal hemorrhage: clinical outcomes in 128 patients at a single institution over a 12-years period. J Vasc Interv Radiol. 2012;23(2):227–35.
Funes FR. Silva R de CMA da, Arroyo PC, Duca WJ, Silva AAM da, Silva RF da: Mortality and complications in patients with portal hypertension who underwent transjugular intrahepatic portosystemic shunt (TIPS)—12 years experience. Arquivos de gastroenterologia. 2012;49(2):143–9.
Toomey PG, Ross SB, Golkar FC, Hernandez JM, Clark WC, Luberice K, Alsina AE, Rosemurgy AS. Outcomes after transjugular intrahepatic portosystemic stent shunt: a bridge to nowhere. Am J Surg. 2013;205(4):441–6.
Russo MW, Zacks SL, Sandler RS, Brown RS. Cost-effectiveness analysis of transjugular intrahepatic portosystemic shunt (TIPS) versus endoscopic therapy for the prevention of recurrent esophageal variceal bleeding. Hepatology. 2000;31(2):358–63.
Damico G, Luca A. TIPS is a cost effective alternative to surgical shunt as a rescue therapy for prevention of recurrent bleeding from esophageal varices. J Hepatol. 2008;48(3):387–90.
Boyer TD, Henderson JM, Heerey AM, Arrigain S, Konig V, Connor J, Abu-Elmagd K, Galloway J, Rikkers LF. Cost of preventing variceal rebleeding with transjugular intrahepatic portal systemic shunt and distal splenorenal shunt. J Hepatol. 2008;48(3):407–14.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of interest
There is no conflict of interest to be declared by any of the authors. There are no potential benefits from a commercial party related to the manuscript subject to be declared by any of the authors.
Statement of Human and Animal Rights
For this type of study, formal consent was not required.
Rights and permissions
About this article
Cite this article
Lauermann, J., Potthoff, A., Mc Cavert, M. et al. Comparison of Technical and Clinical Outcome of Transjugular Portosystemic Shunt Placement Between a Bare Metal Stent and a PTFE-Stentgraft Device. Cardiovasc Intervent Radiol 39, 547–556 (2016). https://doi.org/10.1007/s00270-015-1209-x
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00270-015-1209-x